Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...
Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its first ...
3don MSN
More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...
Medical experts have long warned about alcohol's risks, and now the drinks industry is embracing sobriety, investing in ...
Daniel Mitchell-Jones, co-founder of modelling agency Chapter Management, said: "Yes, things have shifted. In 2020 and 2021, we saw so much more diversity and inclusion on the runways - but body-wise, ...
9h
GlobalData on MSNBain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...
1d
Pharmaceutical Technology on MSNNovo Nordisk plans new study for CagriSema, targets 2026 submissionCagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...
With weight loss drugs such as Ozempic and Mounjaro seemingly able to melt the pounds away, you might well think you'll never need a 'diet plan' again. Alas, you'd be wrong. As a leading weight ...
Emma, who was “fed up” with nothing working, did her research and came across Mounjaro. The self-injectable medication is primarily used to treat type 2 diabetes, but more recently ...
The Dow Jones rose Thursday after surprise weekly jobless claims. Nvidia partner Arm stock tumbled on earnings, while Roblox ...
But after seeing a friend slim down on the weight loss jab Mounjaro, Alison decided to take it too. After a consultation with a leading pharmacy, she was approved to take the drug, for around £ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results